Skip to main content
Top
Published in: Journal of Mammary Gland Biology and Neoplasia 2/2010

01-06-2010 | Preface

Mammary Gland Studies as Important Contributors to the Cause of Epithelial Mesenchymal Plasticity in Malignancy

Authors: H. L. Ford, E. W. Thompson

Published in: Journal of Mammary Gland Biology and Neoplasia | Issue 2/2010

Login to get access

Excerpt

Over the last few years, the field of epithelial-mesenchymal transition (EMT) has rapidly expanded, both in developmental biology and in disease pathology (Fig. 1a). The growing literature suggests that this field may perhaps more appropriately be referred to as epithelial-mesenchymal plasticity (EMP), in light of the increased evidence for the reverse transition (MET), and for the ‘hybrid state’, in which cells express both epithelial and mesenchymal markers. Breast cancer research has always been well represented in the cancer EMT literature (Fig. 1b) and studies of EMT in normal mammary function that may relate to tumour biology are emerging and are adding to the total number of mammary-related EMT papers (Fig. 1c). This Special Issue entitled “EMT in Mammary Development and Breast Cancer Progression” captures much of the current themes in mammary biology and EMP, arranged somewhat chronologically.
Literature
1.
go back to reference Mani SA et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell. 2008;133:704–15.CrossRefPubMed Mani SA et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell. 2008;133:704–15.CrossRefPubMed
4.
go back to reference Tarin D, Thompson EW, Newgreen DF. The fallacy of epithelial mesenchymal transition in neoplasia. Cancer Res. 2005;65:5996–6000. discussion 6000-5991.CrossRefPubMed Tarin D, Thompson EW, Newgreen DF. The fallacy of epithelial mesenchymal transition in neoplasia. Cancer Res. 2005;65:5996–6000. discussion 6000-5991.CrossRefPubMed
5.
go back to reference Thompson EW, Newgreen DF, Tarin D. Carcinoma invasion and metastasis: a role for epithelial-mesenchymal transition? Cancer Res. 2005;65:5991–5. discussion 5995.CrossRefPubMed Thompson EW, Newgreen DF, Tarin D. Carcinoma invasion and metastasis: a role for epithelial-mesenchymal transition? Cancer Res. 2005;65:5991–5. discussion 5995.CrossRefPubMed
Metadata
Title
Mammary Gland Studies as Important Contributors to the Cause of Epithelial Mesenchymal Plasticity in Malignancy
Authors
H. L. Ford
E. W. Thompson
Publication date
01-06-2010
Publisher
Springer US
Published in
Journal of Mammary Gland Biology and Neoplasia / Issue 2/2010
Print ISSN: 1083-3021
Electronic ISSN: 1573-7039
DOI
https://doi.org/10.1007/s10911-010-9182-0

Other articles of this Issue 2/2010

Journal of Mammary Gland Biology and Neoplasia 2/2010 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine